
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 1030 | 1064 | 1040 | 1303 | 1548 |
Fund Return | 6.43% | 3.02% | 6.4% | 1.31% | 5.43% | 4.47% |
Place in category | 154 | 141 | 218 | 292 | 256 | 168 |
% in Category | 43 | 39 | 56 | 78 | 77 | 82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Laudus US Large Cap Growth | 2.04B | -1.73 | 12.15 | 13.88 | ||
Laudus Mondrian Emerging Markets In | 20.04M | 5.60 | 1.09 | 1.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Europacific Growth R | 62.73B | 5.68 | 3.95 | 5.66 | ||
Vanguard International Growth Adm | 37.78B | 7.27 | 3.14 | 8.79 | ||
American Funds Europacific Growth A | 19.21B | 5.62 | 3.56 | 5.28 | ||
American Funds Europacific Growth F | 19.74B | 5.66 | 3.84 | 5.55 | ||
WCM Focused International Growth I | 17.74B | 9.79 | 5.73 | 9.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Schwab Emerging Markets Equity | US8085247067 | 2.61 | 28.11 | +0.54% | |
Msci Eafe Mar25 Ifus 20250321 | - | 2.30 | - | - | |
Novo Nordisk B | DK0062498333 | 1.28 | 478.9 | -0.36% | |
Novartis | CH0012005267 | 1.09 | 98.41 | +0.12% | |
Roche Holding Participation | CH0012032048 | 0.95 | 295.40 | +0.34% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review